The alliance between 3D Systems and Theradaptive serves as a testament to the increasing interconnectedness of the “3D printing sector” and the “medical field”. This intertwining paves the way for new horizons in regenerative treatments.
An Exclusive Partnership Fostering Technological Evolution
3D Systems, renowned for their achievements in 3D printing, recently inked a deal with the biopharmaceutical trailblazer, Theradaptive. This collaboration designates 3D Systems as the sole 3D-printing ally of Theradaptive. Both entities aspire to revolutionize bone and tissue augmentation by employing Theradaptive’s distinctive protein-based materials on 3D-printed medical tools.
The Origins of Theradaptive’s Innovative Tech
Luis M. Alvarez, the brain behind Theradaptive’s protein-engineering innovation, embarked on this journey after observing severe injuries leading to subsequent amputations in servicemen. His intensive studies at MIT centered around refining regenerative medicine techniques, aiming for utmost precision and sustained therapeutic delivery. Preliminary implementations of his innovation have garnered three FDA Breakthrough Medical Device recognitions, addressing spinal issues and related diseases.
A Decade-long Legacy of 3D Systems
With a history spanning over ten years, 3D Systems has collaborated extensively with medical experts, crafting patient-specific plans for over 150,000 cases. Furthermore, they’ve produced over two million CE-marked and FDA-approved implants and tools. Their dedication to the cause is evident in their recent strides in regenerative medicine, exemplified by their Regenerative Tissue Program.
Echoing the sentiment, Theradaptive’s CEO, Alvarez, expressed enthusiasm about this collaboration. He said, “Blending 3D Systems’ pioneering advancements in orthopedic and soft tissue 3D printing with Theradaptive’s therapeutic innovations heralds enhanced treatment avenues for patients. This union foresees an array of products that might elevate patient care standards substantially.”
The partnership’s depth is further emphasized by 3D Systems’ substantial $8 million investment in Theradaptive.
About Theradaptive
Established in 2016 and operating out of Maryland, U.S., Theradaptive stands as a venture-supported biopharmaceutical and medical equipment entity. Their mission centers on utilizing their “therapeutic delivery system” to precisely and consistently channel biologics to targeted areas, addressing prevailing medical challenges. This groundbreaking platform is propelling the creation of novel treatments spanning spinal care, orthopedics, soft tissue restoration, and specialized immuno-oncology.
Except:
The collaboration between 3D Systems and Theradaptive signifies the growing synergy of the 3D printing realm with medical innovations, aiming for breakthroughs in regenerative treatments.
